15 Israeli biomedical companies will attend the MarketReach America conference, which Johns Hopkins University will hold in Baltimore later this month. The conference is being organized by the Maryland/Israel Development Center and Trendlines International Ltd. The conference is intended to help Israeli biomedical companies penetrate international markets.
Participating companies include Rad BioMed Incubator, Lavi Cardiovascular Ltd., NanoVibronix Inc., Pro-IV Ltd., and Immunovative Therapies Ltd., which is based at Misgav Technology Center (owned by Trendlines).
Participating US companies include Medtronic Inc. (NYSE:MDT), Becton Dickinson & Co. (NYSE:BDX), Martek Biosciences Corp. (Nasdaq:MADK), Novation, AstraZeneca plc (NYSE; LSE:AZN), MedImmune Inc. (Nasdaq:MEDI) and Hanger Orthopedic Group Inc. (NYSE:HGR).
Maryland Governor Martin O’Malley and Israel Ambassador to the US Sallai Meridor will also attend the conference. Maryland is a center of the US life sciences industry, since the state is the home of the Food and Drug Administration (FDA) and the National Institutes of Health (NIH).
Published by Globes [online], Israel business news - www.globes.co.il - on July 12, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007